Tag: Brexit GMP impact

Brexit Impact on UK-EU GMP Inspection Alignment Brexit and Its Impact on UK-EU GMP Inspection Alignment The UK’s departure from the European Union has significantly altered the pharmaceutical regulatory landscape, especially regarding Good Manufacturing Practice (GMP) inspections. Prior to Brexit, the UK operated within the EU regulatory framework coordinated by the European Medicines Agency (EMA)….

Read More “Brexit Impact on UK-EU GMP Inspection Alignment” »